Extended Data Fig. 5: Increased quantitative abundance of Eggerthella in the Bact2 enterotype of the non-statin-medicated BMIS cohort.
From: Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
a, Difference in quantitative Eggerthella abundances between enterotypes (Prev = Rum < Bact1 < Bact2; n = 771 biologically independent samples, Kruskal–Wallis Padj = 4.10 × 10−47; different letters denote enterotypes with a significant pairwise difference (post hoc Dunn tests provided in Supplementary Table 10)). Adjustment for multiple testing (Padj) was performed using the Benjamini–Hochberg method. b, Difference in the proportion of Eggerthella (normalized by the sample total microbial load) between enterotypes, showing a comparable trend to that seen in a (n = 771 biologically independent samples). The body of the box plot represents the first and third quartiles of the distribution, the line represents the median, and the whiskers extend from the quartiles to the last data point within 1.5× IQR, with outliers beyond.
